SEGMENT REPORTING (Tables)

12 Months Ended

Dec. 31, 2024

Segment Reporting [Abstract]

Schedule of segment reporting

	As of December 31,
Asset:	2024		2023
Healthcare	$	21,298,866	$	18,955,991
Real Estate		576,478		587,456
Corporate		2,050,335		1,202,364
Consolidated assets	$	23,925,679	$	20,745,811

	Years Ended December 31,
	2024			2023
Revenues:
Healthcare	$	8,720,176		$	11,853,266
Real Estate		–			–
Consolidated revenues	$	8,720,176		$	11,853,266
Cost of Sales:
Healthcare	$	3,841,628		$	3,560,624
Real Estate		–			–
Consolidated cost of sales	$	3,841,628		$	3,560,624
Operating Expenses:
Healthcare
Depreciation expense	$	13,461		$	20,777
Selling, General and Administrative		1,148,971			971,016
Total Healthcare		1,162,432			991,793
Real Estate		8,949			3,716
Corporate, administration and other expenses (a)		3,450,621			2,102,088
Consolidated Operating Expenses	$	4,622,002		$	3,097,597
Income (Loss) from Operations from Subsidiaries:
Healthcare	$	3,266,065		$	7,300,849
Real Estate		(8,949	)		(3,716	)
Income (loss) from operations from subsidiaries		3,257,116			7,297,133
Loss from operations from Cardiff Lexington		(3,450,620	)		(2,102,088	)
Total income (loss) from operations	$	(193,504	)	$	5,195,045
Income (Loss) before taxes
Healthcare	$	3,266,065		$	5,973,233
Real Estate		(8,949	)		(3,716	)
Corporate, administration and non-operating expenses (b)		(6,448,803	)		(2,854,603	)
Consolidated income (loss) before taxes	$	(3,191,687	)	$	3,114,914

(a) Corporate, administration and other operating expenses includes payroll, management fees, stock compensation, legal fees, accounting fees and public company/investor relations fees.

(b) Corporate, administration and other non-operating expenses includes corporate selling, general and administrative expenses as noted above as well as interest, amortization of notes payable discount and gain on settlement of debt.